Commonwealth Equity Services
TNXP icon

Commonwealth Equity Services’s Tonix Pharmaceuticals TNXP Stock Holding History

Commonwealth Equity Services’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,203
Closed -$40K – 4286
2024
Q4 		$40K Buy
+1,203
New +$25K ﹤0.01% 4000
2024
Q2 		– Sell
-7
Closed -$4K – 4170
2024
Q1 		$4K Buy
7
+1
+17% +$1.08K ﹤0.01% 4010
2023
Q4 		$8K Hold
6
– – ﹤0.01% 3873
2023
Q3 		$11K Buy
6
+3
+100% +$11K ﹤0.01% 3774
2023
Q2 		$16K Buy
3
+1
+50% +$7.58K ﹤0.01% 3763
2023
Q1 		$22 Hold
2
– – ﹤0.01% 3661
2022
Q4 		$14K Buy
+2
New +$17.3K ﹤0.01% 3626

Other funds holding TNXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return

Commonwealth Equity Services's TNXP Position: Q1 2025 in Review

Commonwealth Equity Services sold out of Tonix Pharmaceuticals (TNXP) in Q1 2025, closing a stake of 1,203 shares — an estimated $40K sold.

Commonwealth Equity Services first reported a position in TNXP in Q4 2022 and held it in 7 quarters. The position peaked at $40K in Q4 2024. 26 funds tracked by Wall St. Rank hold TNXP as of Q1 2025.

  • Commonwealth Equity Services reported no remaining Tonix Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,203 Tonix Pharmaceuticals shares in Q1 2025, an estimated $40K.
  • Commonwealth Equity Services first reported a position in Tonix Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • Commonwealth Equity Services's Tonix Pharmaceuticals position peaked at $40K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.